Ausgabe 4/2002
Inhalt (23 Artikel)
Commentary
The International Sepsis Forum's controversies in sepsis: how will sepsis be treated in 2051?
Edward Abraham
Commentary
Immunodepression in the surgical patient and increased susceptibility to infection
Hans-Dieter Volk
Commentary
Lactate: A key metabolite in the intercellular metabolic interplay
Xavier M Leverve, Iqbal Mustafa
Commentary
Pro/con clinical debate: do colloids have advantages over crystalloids in paediatric sepsis?
Puran Khandelwal, Desmond Bohn, Joseph A Carcillo, Neal J Thomas
Commentary
Endotoxemia in critically ill patients: why a reliable test could be beneficial
Robert A Balk
Review
Clinical review: Immunodepression in the surgical patient and increased susceptibility to infection
Martin K Angele, Eugen Faist
Review
Clinical review: Use of vancomycin in haemodialysis patients
Vincent Launay-Vacher, Hassane Izzedine, Lucile Mercadal, Gilbert Deray
Open Access
Research
Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence
John C Marshall, Paul M Walker, Debra M Foster, David Harris, Melanie Ribeiro, Jeff Paice, Alexander D Romaschin, Anastasia N Derzko
Open Access
Research
The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis [ISRCTN28863830]
Simru Tugrul, Perihan Ergin Ozcan, Ozkan Akinci, Yalcin Seyhun, Atahan Cagatay, Nahit Cakar, Figen Esen
Open Access
Research
Expression of the C5a receptor (CD88) on granulocytes and monocytes in patients with severe sepsis
Mia Furebring, Lena Douhan Håkansson, Per Venge, Bo Nilsson, Jan Sjölin
Open Access
Research
Need for critical care in gynaecology: a population-based analysis
Seppo Heinonen, Esko Tyrväinen, Jorma Penttinen, Seppo Saarikoski, Esko Ruokonen
Open Access
Research
Quality of life effects of antithrombin III in sepsis survivors: results from the KyberSept trial [ISRCTN22931023]
Dale Rublee, Steven M Opal, Wolfgang Schramm, Heinz-Otto Keinecke, Sigurd Knaub